Lance Alstodt bought $1,244 of BRTX
President, CEO, COB at BioRestorative Therapies, Inc.. 400 shares at an average of $3.11, traded Jan 18, 2023, filed Jan 20, 2023.
Score components
- +25RoleCEO
- 0Trade size$1k at market
- -5Relative to holdingsUnder 1% of holdings (0.2%)
- +8Price context46% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying5 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001567619-23-001056, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 18, 2023 | POpen-market purchase Common Stock | +200 | $3.13 | $626 | 186,321 | Jan 20, 2023 |
| Jan 18, 2023 | POpen-market purchase Common Stock | +100 | $3.10 | $310 | 186,421 | Jan 20, 2023 |
| Jan 18, 2023 | POpen-market purchase Common Stock | +100 | $3.09 | $309 | 186,521 | Jan 20, 2023 |
Related signals
Other insiders at BioRestorative Therapies, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $1,757 1,112 shares | -0% | |
| 36Weak | BRTXbuy BioRestorative Therapies, Inc. | Francisco Silva VP of Research and Development | $10k 8,308 shares | +6% | |
| 52Moderate | BRTXbuy BioRestorative Therapies, Inc. | Dale Broadrick owner | $206k 160,000 shares | +50% | |
| 42Moderate | BRTXbuy BioRestorative Therapies, Inc. | Dale Broadrick owner | $162k 120,000 shares | +37% | |
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $469 250 shares | -0% | |
| 12Weak | BRTXsell BioRestorative Therapies, Inc. | Dale Broadrick owner | $525 278 shares | -0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $1,241 400 shares | +0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $602 200 shares | +0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $627 200 shares | +0% | |
| 33Weak | BRTXbuy BioRestorative Therapies, Inc. | Lance Alstodt President, CEO, COB | $308 100 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.